On November 9, 2021 Neoleukin Therapeutics, Inc., "Neoleukin" (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, reported that management will participate in two upcoming investor conferences (Press release, Neoleukin Therapeutics, NOV 9, 2021, View Source [SID1234594981]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation Details:

Event: Stifel 2021 Virtual Healthcare Conference
Date: Tuesday, November 16, 2021
Time: 3:20 to 3:50 p.m. EST
Format: Fireside chat

Event: Piper Sandler 33RD Annual Virtual Healthcare Conference
Date: Monday, November 22, 2021
Time: Available on-demand starting 10:00 a.m. EST
Format: Fireside chat

The presentations will be available from the investors section of the Neoleukin website at View Source An archived replay will also be available on the company website for at least 30 days following the event.